caramiphen hydrogen edisilate

• CAT Number: M133152
• CAS Number: 125-86-0
• Molecular Formula: C38H60N2O10S2
• Molecular Weight: 769.02
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: 2-(diethylamino)ethyl 1-phenylcyclopentane-1-carboxylate;ethane-1,2-disulfonic acid
• InChI: InChI=1S/2C18H27NO2.C2H6O6S2/c2*1-3-19(4-2)14-15-21-17(20)18(12-8-9-13-18)16-10-6-5-7-11-16;3-9(4,5)1-2-10(6,7)8/h2*5-7,10-11H,3-4,8-9,12-15H2,1-2H3;1-2H2,(H,3,4,5)(H,6,7,8)
• InChIKey: BANIDACEBXZGNK-UHFFFAOYSA-N
• SMILES: CCN(CC)CCOC(=O)C1(CCCC1)C2=CC=CC=C2.CCN(CC)CCOC(=O)C1(CCCC1)C2=CC=CC=C2.C(CS(=O)(=O)O)S(=O)(=O)O

Caramiphen hydrogen isolate（Cat No.:M133152） is a quaternary ammonium anticholinergic agent used primarily as a bronchodilator and anti-spasmodic medication. It acts by blocking the action of acetylcholine at muscarinic receptors, thereby relaxing smooth muscles in the airways and reducing bronchoconstriction. This drug is used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Caramiphen hydrogen isolate is typically administered orally or via inhalation, and its effects are relatively rapid. However, it may cause side effects such as dry mouth, blurred vision, and urinary retention.